Affordable Access

deepdyve-link
Publisher Website

Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies.

Authors
  • Kacskovics, Imre
  • Cervenak, Judit
  • Erdei, Anna
  • Goldsby, Richard A
  • Butler, John E
Type
Published Article
Journal
mAbs
Publisher
Landes Bioscience
Publication Date
Jan 01, 2011
Volume
3
Issue
5
Pages
431–439
Identifiers
DOI: 10.4161/mabs.3.5.17023
PMID: 22048692
Source
Medline
License
Unknown

Abstract

This review illustrates the salutary effects of neonatal Fc receptor (FcRn) overexpression in significantly improving humoral immune responses in the generation of antibodies for immunotherapy and diagnostics. These include: (1) improved IgG protection; (2) augmented antigen-specific humoral immune response with larger numbers of antigen specific B cells, thus offering a wider spectrum of clones; (3) generation of antibodies against weakly immunogenic antigens; (4) significant improvements in the number and substantial developments in the diversity of hybridomas. FcRn transgenesis thus confers a number of practical benefits, including faster antibody production, higher antibody yields and improved generation of hybridomas for monoclonal antibody production. Notably, these efficiencies in polyclonal antibody production were also demonstrated in FcRn transgenic rabbits. Overall, FcRn transgenic animals yield more antibodies and provide a route to the generation of antibodies against antigens of low immunogenicity that are difficult to obtain using currently available methods.

Report this publication

Statistics

Seen <100 times